Pinpoint Genomics Publishes Results of Dx Lung Assay Study
The report in The Lancet describes the development of the assay based on specimens from 361 patients who underwent surgery at the University of California, San Francisco.
Read MorePosted by Clinical Lab Products | Feb 6, 2012 | Cancer, Miscellaneous |
The report in The Lancet describes the development of the assay based on specimens from 361 patients who underwent surgery at the University of California, San Francisco.
Read MorePosted by Clinical Lab Products | Feb 4, 2012 | Cancer, Miscellaneous |
Lale White, executive chairman and CEO, XIFIN Economic pressures, legislative mandates, and technological advancements are driving significant changes in the diagnostic services segment, while reimbursement for lab testing and diagnost
Read MorePosted by Clinical Lab Products | Feb 1, 2012 | Cancer, Computing Systems, Information Technology, Middleware & Software, Pancreatic |
Changing the role of informatics in personalized medicine
Read MorePosted by Clinical Lab Products | Jan 31, 2012 | Cancer, Miscellaneous, Pancreatic |
A mutant protein found in nearly all pancreatic cancers plays a role not only in the cancer’s development but in its continued growth.
Read MorePosted by Clinical Lab Products | Jan 31, 2012 | Cancer, Miscellaneous |
bioTheranostics Inc introduces a new product line of high medical value biomarkers for response, resistance, and pathway interrogation called PRECIS Precision Medicine.
Read More